Antibiotics: Cephalosporins Flashcards
1st generation cephalosporin (cefazolin, cephalexin) coverage:
Most streptococci, MSSA, most oral anaerobes, some sensitive GNRs (like E. coli).
Little use against MRSA, ENTEROCOCCUS, nosocomial GNRs, bowel anaerobes.
1st generation cephalosporin indications:
Soft tissue infections (staph and strep), UTIs, patients with MILD penicillin allergies.
2nd generation cephalosporin (cefuroxime, cefotetan) coverage:
Similar coverage as 1st generations, but slightly less activity against GPCs and more activity against GNRs (Klebsiella, B. fragilis)
3rd generation cephalosporin (ceftriaxone, ceftazidime) coverage:
Streptococci, MSSA, pneumococcus, most oral anaerobes, Neisseria, MOST GNRs, Lyme disease. CEFTAZIDIME COVERS PSEUDOMONAS.
Little use against MRSA, enterococcus, nosocomial GNRs, bowel anaerobes.
3rd generation cephalosporin indications:
Meningitis, serious pneumonia, GONORRHEA, otitis, sinusitis.
5th generation cephalosporin (ceftaroline) coverage:
Many GNRs (E. coli, Klebsiella, H. flu), many GPCs (including MRSA and MSSA).
Cephalosporin adverse effects:
Can produce similar allergic reactions as penicillins. DO NOT GIVE TO PEOPLE WITH SERIOUS PENICILLIN ALLERGIES.
Meropenem coverage:
Most GPCs, most GNRs (except Pseudomonas), and all anaerobes. MRSA is resistant.
Meropenem indications:
Mixed nosocomial infections with resistant GNRs, complicated meningitis, peritonitis, serious pneumonia, sepsis. GOOD CSF PENETRATION.
Monobactams (aztreonam) coverage:
ONLY AEROBIC GNRs. Tolerated by virtually all patients who are allergic to penicillin.
Vancomycin coverage:
All GPCs (MSSA, MRSA) and C. diff. All GNRs are resistant.
Vancomycin side effects:
May cause RED MAN SYNDROME with rapid infusion. Also, neutropenia and nephrotoxicity.
Vancomycin indications:
Empiric treatment for serious infections likely caused by GPCs, treatment for serious infections caused by GPCs that are resistant to other drugs. ORAL TREATMENT for C. diff.
Vancomycin is synergistic with ___ against ___:
Gentamicin, enterococcus or staphylococci.
Daptomycin coverage:
Most GPCs. All GNRs are resistant.